PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24432369-0 2013 Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-kB signaling pathway in isoproterenol-induced myocardial hypertrophy. Isoproterenol 97-110 RELA proto-oncogene, NF-kB subunit Rattus norvegicus 70-75 34599475-11 2022 ISO administration in heart tissue is regulated by gossypin with increased SOD activity, GSH amount, TNF-alpha, IL-6, IL-1beta, and NF-kB mRNA expression levels and decreased MDA amount. Isoproterenol 0-3 RELA proto-oncogene, NF-kB subunit Rattus norvegicus 132-137 32356088-0 2021 Gentianella acuta prevents acute myocardial infarction induced by isoproterenol in rats via inhibition of galectin-3/TLR4/MyD88/NF-kB inflammatory signalling. Isoproterenol 66-79 RELA proto-oncogene, NF-kB subunit Rattus norvegicus 128-133 32356088-11 2021 The study indicated that pre-treatment with G. acuta protects against ISO-induced AMI, and the protective role may be related to inhibiting Gal-3/TLR4/MyD88/NF-kB inflammatory signalling. Isoproterenol 70-73 RELA proto-oncogene, NF-kB subunit Rattus norvegicus 157-162 32344394-0 2020 Design and Development of Novel Pyrazole-Thiadiazole Derivatives as NF-kB Inhibitor and Cardioprotective Effect against Isoproterenol Induced Myocardial Infarction in Sprague-Dawley Rats. Isoproterenol 120-133 RELA proto-oncogene, NF-kB subunit Rattus norvegicus 68-73 32344394-1 2020 The present study was aimed to discover novel pyrazole-thiadiazole derivatives as potent NF-kB inhibitor and its cardioprotective effect against isoproterenol (ISO)-induced myocardial infarction (MI) in rats. Isoproterenol 145-158 RELA proto-oncogene, NF-kB subunit Rattus norvegicus 89-94 32344394-1 2020 The present study was aimed to discover novel pyrazole-thiadiazole derivatives as potent NF-kB inhibitor and its cardioprotective effect against isoproterenol (ISO)-induced myocardial infarction (MI) in rats. Isoproterenol 160-163 RELA proto-oncogene, NF-kB subunit Rattus norvegicus 89-94